avtar dhillon

No Image

Inovio Biomedical (AMEX: INO): A DNA Vaccine Delivery Innovator

October 8, 2009 vanderson 0

Inovio Biomedical (AMEX: INO) is developing a robust pre-clinical and early clinical stage pipeline of innovative DNA-based vaccines and therapeutics that target cancer, influenza, and other infectious diseases (e.g. HIV) based on its SynCon DNA vaccine construct and electroporation DNA delivery technology platforms.

No Image

[Video Profile] Inovio Biomedical Corporation

March 26, 2009 bjohnson56 0

Solid tumors represent 85 percent of all cancers, creating a huge clinical need for localized, site-specific cancer treatment. Inovio Medical Corporation of San Diego is developing DNA-based vaccines that harness the body’s immune system to prevent and treat chronic diseases such as cancer and HIV.